President Donald Trump signed an executive order on April 15 that directs a wide range of actions to lower the cost of prescription medications, including through the importation of prescription drugs from Canada by the states.
States have been authorized since 2020 to import certain drugs from Canada—where they are often available at a lower price—under section 804 of the Food, Drug and Cosmetics Act. However, approval from the Food and Drug Administration is required, and that process is complex.
